key: cord-0709092-3tdj1yy5
authors: Rogg, Jeffrey; Baker, Amanda; Tung, Glenn
title: Posterior Reversible Encephalopathy Syndrome: A Manifestation of COVID-19 Cytokine Storm
date: 2020-06-22
journal: Interdiscip Neurosurg
DOI: 10.1016/j.inat.2020.100808
sha: 40fdef5d9c29b7ef36f0b2812f38d3141f8b9570
doc_id: 709092
cord_uid: 3tdj1yy5

Neuroimaging manifestations of COVID-19 are being reported with increasing frequency with recent reports of associated atypical leukoencephalopathies. We add to this literature by describing a COVID-19 + patient who demonstrated imaging findings typical for posterior reversible encephalopathy syndrome (PRES). The inflammatory syndrome associated with novel corona virus infection has shown markedly increased levels of cytokines and inflammatory markers. This has also been described in a proposed mechanism for PRES, where elevated inflammatory markers result in endothelial injury causing interstitial fluid extravasation typical of PRES. We expect that other cases of PRES will be observed in this population given the scope of the Covid-19 pandemic.

virus primarily manifests as a respiratory illness characterized by cough and sore throat that may progress to acute respiratory distress syndrome given its effect on the lower airways 2,3 . As of April 21, 2020 the World Health Organization reported 2,319,066 confirmed cases of COVID-19 worldwide 4 .

We describe imaging findings of posterior reversible encephalopathy syndrome (PRES) in a 59-years old man without significant past medical history who initially presented to the hospital with fever, respiratory distress and tested positive for COVID-19. On admission the oxygen-saturation was 93% on 4L oxygen by nasal cannula. On the second day of admission, he developed acute respiratory failure requiring intubation and was transfer to the intensive care unit. The patient received a seven-day course of Ceftriaxone and three doses of azithromycin for persistent fever during his admission. He was also enrolled in a trial utilizing the antiviral remdesivir.

During the hospital course, his BUN level fluctuated however eGFR remained within normal range (> 60 cc/min). Blood pressure lability was recorded during the hospital course never exceeding a one day maximum of 173/96 mmHg, that had decreased prior to the time of imaging. Despite treatment and maintenance of oxygen saturation, progressive respiratory compromise occurred. With cessation of paralytics, the patient was found to be encephalopathic so brain imaging was requested. Non-contrast necrotizing encephalitis related to the COVID-19 infection and ascribed their findings to the related "cytokine storm" seen with the infection 12 . Also recently described is a report of a non-specific confluent posterior predominant white matter leukoencephalopathy, with scattered micro-hemorrhage most notably at the corpus callosum. The considered differential diagnosis included ADEM/AHEM and PRES with associated microhemorrhage. Notably their patient described showed no evidence for preexisting hypertension or other risk factors for PRES. 13 In our case, the imaging features were highly typical for PRES, showing confluent predominantly posterior subcortical and external capsule edema signal, with increased diffusivity and no associated contrast enhancement. Although our reported patient had labile hypertension during his hospital course, that could have contributed to the pathophysiology of PRES, his blood pressure had stabilized and was reduced by the time that imaging occurred.

The pathophysiology of PRES is controversial, originally attributed to autoregulation breakthrough or vasospasm-induced ischemia 14 . As reported etiologies expanded, a more widely inclusive pathophysiological mechanism has achieved consensus. In this concept PRES is thought to be initiated by a combination of endothelial injury and hypoperfusion of brain tissue that is often the result a systemic process in which increased levels of cytokines and inflammatory markers cause endothelial damage via upregulation of endothelial surface antigens and increased leukocyte adherence 14-16 . Indeed, increased levels of serum cytokines have been found in the highly pathogenic coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2, and correlate with the severity of the clinical disease 3 . In addition to the Th1 T-cellsecreted cytokines, high levels of cytokines produced by Th2 T-cells, which include IL-4 and IL-10, are specific to SARS-CoV-2 3, 17 . Multiple studies have linked the severity of COVID-19 symptoms and progression to ARDS to increased level of cytokines and inflammatory markers including IL-2R, IL-6, IP-10, MCP-1, TNF-α, granulocyte colony-stimulating factor, and macrophage inflammatory protein-1A 17-19. Therefore, in this context, the typical manifestations of extensive PRES in a patient infected with Covid-19

is not unexpected and is demonstrated in the presented case. We posit that PRES in this instance is primarily secondary to the "cytokine storm" associated with the pathogenesis of SARS-CoV-2 infections.

We expect that other cases of PRES will be observed in this population given the scope of the Covid-19 pandemic. 

Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

WHO COVID-19 Dashboard

Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features

Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study. Infectious Diseases (except HIV/AIDS)

Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology

Presentation of new onset anosmia during the COVID-19 pandemic

Neurologic complications of coronavirus infections

Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)

COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

COVID-19 Associated Leukoencephalopathy. Radiology, 2020 -pubs.rsna.org 14. Bartynski WS. Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema

Cytokine regulation of endothelial cell function

Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical and immunological features of severe and moderate coronavirus disease 2019